| Syndrome | Examples of associated drugs | References |
| Immunohemolytic anemia | Pencillins, cephaloporins, alpha-methyl-DOPA, oxaliplatin, fludarabine, anti-Rh D antiglobulin | [1–4] | Nonimmune hemolytic anemia | Ribavirin, phenazopyridine, chloroquine, | [5, 6] | Methhemoglobinemia | Phenazopyridine, dapsone, benzocaine, prilocaine | [7–13] | Megaloblastic anemia | Rrimethoprim, pyrimethamine, diphenyhydantoin | [14–16] | Sideroblastic anemia | Isoniazid, chloramphenicol, linezolide | [17–22] | Aplastic anemia | Chloramphenical, gold, NSAIDs, | [23–27] | Pure red cell aplasia | Diphenylhydantoin, azathioprine, chlopropamide, isoniazid, erythropoietin | [28–33] | Immune thrombocytopenia | Quinine, quinidine, heparin, vancomycin, sulfas, pencillins, glycoprotein IIb-IIIa inhibitors | [34–40] | Thrombotic microangiopathy | Quinine, quinidine, clopidogrel, ticlopidine, cylosporine A, mitomycin-C, cisplatin | [41–45] | Platelet dysfunction | Pencillins, beta-lactam antibiotics, aspirin, NSAIDs | [46, 47] | Hypercoagulability | Estrogens, tamoxifen, asparaginase, heparin, bevacizumab, thalidomide/lenalidomide, COX-2 inhibitors, erythropoietin | [48–66] | Circulating anticoagulants | Isoniazid, hydralazine, procainamide | [67–70] | Hypoprothrombinemia | Cephalosporins, pencillins, sulfas | [71–73] | Neutropenia | Antithyroid drugs, procainamide, sulfas, captopril, phenothiazines, diphenylhydantoin, rituximab | [74–77] | Neutrophilia | Glucocorticoids, lithium, G- and GM-CSF | [78–81] | Eosinophilia | Pencillins, sulfas, allopurinol, diphenylhydantoin | [82, 83] | Polycythemia | Erythropoietin, anabolic steroids, diuretics | [84] | Acute leukemia/myelodyplasia | Alkylating agents, topoisomerase II inhibitors | [85–95] |
|
|